Angiotensin II Decreases Cholesterol 27-Hydroxylase Expression and Promotes Foam Cell Formation in THP-1

Gang Tian,Lu Min,Lu Qun,Zhang Yong,Wang Ya Ping
DOI: https://doi.org/10.1016/j.ijcard.2009.09.015
IF: 4.039
2009-01-01
International Journal of Cardiology
Abstract:Objectives Imbalances in cellular cholesterol flux within macrophage lead to the formation of foam cells. Recognition of the factors associated with maintaining cholesterol balance may illuminate atherogenesis. Elevation in angiotensin II (Ang II) that has been suggested amplifies atherosclerosis in animal models, but the molecular mechanisms for this interaction are incompletely defined. Design and methods THP-1 human monocytes were differentiated into macrophages in vitro and treated with Ang II (10–10, 10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. The quantities cholesterol 27-hydroxylase mRNA levels and normalized for GAPDH by RT-PCR. Results (1) The THP-1 with various concentrations of Ang II decreased in a time-course and dose-dependence manner, expression of cholesterol 27-hydroxylase mRNA respectively; reaching its maximum after a 24 h incubation; (2) Ang II-induced down regulation was prevented by the AT1 receptor blocker Irbesartan; (3) The decreased cholesterol 27-hydroxylase expression results in the enhancement of foam cell transformation compared to untreated cells; (4) Ang II potential through the AT1-receptor pathway promoted human macrophage-derived foam cell formation. Conclusions Ang II contributes to the pathogenesis of atherosclerosis, in part, by down-regulating the expression of the enzymes required to maintain cholesterol homeostasis in the macrophage, and that this effect is associated with foam cell formation.
What problem does this paper attempt to address?